Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 708 (USA) (Dr. Kim)
· consented 2013-05-09
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild DIZZINESS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-23 (study day 15.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2013-05-23 (study day 15.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild MYOCARDIAL INFARCTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-09 (study day 32.0); relationship: REMOTE
mild
assessed
2026-08-18
Mild MYOCARDIAL INFARCTION — outcome: RECOVERED/RESOLVED; onset 2013-06-09 (study day 32.0); relationship: REMOTE
mild
assessed
2026-08-18
Mild SINUS BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-23 (study day 46.0); relationship: REMOTE
mild
assessed
2026-08-18
Mild SINUS BRADYCARDIA — outcome: RECOVERED/RESOLVED; onset 2013-06-23 (study day 46.0); relationship: REMOTE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.